EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Malaria-diabetes comorbidity is linked to higher parasitaemia and enhanced IgG response to malaria vaccine candidate antigens

Gideon Agyare, David Courtin, Samuel Asamoah Sakyi, Gideon Kwesi Nakotey, Naa Adjeley Frempong iD, Prince Amoah Barnie, Samuel Kofi Tchum, Samuel Victor Nuvor, Benjamin Amoani iD

PLOS One · 06.02.2026 · 21 (2) · e0341659

DOI: 10.1371/journal.pone.0341659 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 06.02.2026. Verfasst von Gideon Agyare und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, School of Medical Sciences, University of Cape Coast, Cape Coast, Ghana. Hauptthemen laut MEDLINE: Immunoglobulin G, Antigens, Protozoan, Diabetes Mellitus, Type 2, Malaria Vaccines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The coexistence of type 2 diabetes mellitus (T2DM) and malaria presents a significant public health concern, particularly in malaria-endemic regions. T2DM’s immunomodulatory effects may influence immune responses to infectious diseases, but its impact on naturally acquired antibodies against malaria vaccine candidate antigens remains unclear. This study investigated how T2DM-malaria comorbidity affects IgG responses to malaria vaccine candidate antigens (GLURP-R2, GLURP-RO, MSP3, MSP1, AMA-1 and CSP) among individuals in the Central Region of Ghana.

Methods

This hospital-based case-control study recruited a total of 144 participants 40 with diabetes, 25 with both diabetes and malaria, 41 with malaria only, and 38 controls (hospital staff without malaria or diabetes matched by age and sex). Malaria status and parasitaemia were confirmed using microscopy, blood glucose levels were measured via glucometer, and antibody levels were quantified using indirect ELISA. Data were analyzed using parametric and non-parametric statistical methods.

Results

Patients with malaria-diabetes comorbidity exhibited significantly higher parasitaemia levels compared to those with malaria alone [1702 (IQR1 = 926.50, IQR3 = 4102) vs. 932 (IQR1 = 722.50, IQR3 = 1321), p = 0.02]. Relative to the negative control group, IgG responses to GLURP-R2 were markedly elevated, showing a 1.60-fold increase in the comorbidity group (β = 0.47 [95% CI: 0.10–0.83], p = 0.01) and a 1.43-fold increase in the malaria-only group (β = 0.36 [95% CI: 0.04–0.69], p = 0.03). Among individuals with comorbidity, IgG levels to GLURP-R0 and MSP1 were also 1.43-fold higher (β = 0.36 [95% CI: 0.03–0.68], p = 0.03) and 1.42-fold (β = 0.35 [95% CI: 0.09–0.61], p < 0.05), respectively. Conversely, antibody responses to MSP3, AMA1, and CSP did not differ significantly between the study groups (p > 0.05). In the multivariate regression model adjusted for age and sex, individuals with comorbidity exhibited significantly elevated IgG responses, showing a 1.38-fold increase to GLURP-R0 (β = 0.32 [95% CI: 0.07–0.59], p = 0.027) and a 1.34-fold higher response to MSP1 (β = 0.29 [95% CI: 0.02–0.47], p = 0.048), relative to the malaria-only group.

Conclusion

These findings suggest that diabetes may enhance malaria parasite multiplication while also augmenting IgG antibody responses to malaria vaccine candidate antigens in individuals with comorbidity. Further research is required to elucidate the mechanisms by which diabetes influences antibody responses to malaria infection and its potential implications for malaria vaccine development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin GAntigens, ProtozoanDiabetes Mellitus, Type 2Malaria VaccinesParasitemiaMalariaHumansFemaleMaleCase-Control StudiesMiddle AgedAdultComorbidityAntibodies, ProtozoanGhana

Substanzen

Immunoglobulin GAntigens, ProtozoanMalaria VaccinesAntibodies, Protozoan

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, School of Medical Sciences, University of Cape Coast, Cape Coast, Ghana.
  • UMR 261 MERIT, Université de Paris, Institute de Recherche pour le Développement (IRD), Paris, France.
  • Department of Molecular Medicine, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Department of Medical Laboratory Technology, Central College of Science and Technology, Agona Swedru, Ghana.
  • Department of Parasitology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.
  • Department of Forensic Science, School of Biological Sciences, College of Agriculture and Natural Sciences, University of Cape Coast, Cape Coast, Ghana.

ORCID-Profile: Naa Adjeley Frempong, Benjamin Amoani

Zitieren

APA

Agyare, G., Courtin, D., Asamoah Sakyi, S., Nakotey, G. K., Adjeley Frempong, N., Barnie, P. A., Tchum, S. K., Victor Nuvor, S., & Amoani, B. (2026). Malaria-diabetes comorbidity is linked to higher parasitaemia and enhanced IgG response to malaria vaccine candidate antigens. PLOS One, 21(2), e0341659. https://doi.org/10.1371/journal.pone.0341659

Vancouver

Agyare G, Courtin D, Asamoah Sakyi S, Nakotey GK, Adjeley Frempong N, Barnie PA, et al. Malaria-diabetes comorbidity is linked to higher parasitaemia and enhanced IgG response to malaria vaccine candidate antigens. PLOS One. 2026;21(2):e0341659. doi:10.1371/journal.pone.0341659

BibTeX
@article{Agyare2026,
  author = {Agyare, Gideon and Courtin, David and Asamoah Sakyi, Samuel and Nakotey, Gideon Kwesi and Adjeley Frempong, Naa and Barnie, Prince Amoah and Tchum, Samuel Kofi and Victor Nuvor, Samuel and Amoani, Benjamin},
  title = {Malaria-diabetes comorbidity is linked to higher parasitaemia and enhanced IgG response to malaria vaccine candidate antigens},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {2},
  pages = {e0341659},
  doi = {10.1371/journal.pone.0341659}
}
Kostenlos starten →